Journal article
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
Abstract
BACKGROUND: Isotretinoin, a teratogen, is widely used to treat cystic acne. Although the risks of pregnancy during isotretinoin therapy are well recognized, there are doubts about the level of adherence with the pregnancy prevention program in Canada. Our objective was to evaluate the effectiveness of the Canadian pregnancy prevention program in 4 provinces: British Columbia, Saskatchewan, Manitoba and Ontario.
METHODS: Using administrative …
Authors
Henry D; Dormuth C; Winquist B; Carney G; Bugden S; Teare G; Lévesque LE; Bérard A; Paterson JM; Platt RW
Journal
Canadian Medical Association Journal, Vol. 188, No. 10, pp. 723–730
Publisher
Joule
Publication Date
July 12, 2016
DOI
10.1503/cmaj.151243
ISSN
0820-3946